MRI-guided radiation for prostate cancer patients
Part of Cancer, Kidney & urinary clinical trials.
This study tests radiation treatment planned and guided using MRI scans (“image-guided radiotherapy”) for men with prostate cancer who are aiming for a cure. If you qualify, you may receive radiation with more precise targeting using MRI to help deliver treatment accurately.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have prostate cancer confirmed by biopsy (histology)
- Your prostate cancer is being treated with the goal of cure
- You can do normal activities or are only mildly limited (ECOG 0–2)
- You are able to give informed consent
- You can safely have MRI scans (no MRI safety problems)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether using MRI scans to guide radiation can allow lower doses to the healthy parts of the prostate, potentially reducing side effects. It is for men with intermediate- or high-risk prostate cancer that can be seen on MRI and has not spread.
This trial tests a newer way to plan and deliver radiation for prostate cancer using real-time MRI guidance. It may help by aiming high-dose treatment precisely while treating nearby disease and (in some cases) limited metastatic spots.
This trial tests a precise, MRI-guided radiation treatment given over 7 days for people with prostate cancer in specific risk categories. It may help shrink or control the cancer while carefully targeting the tumor.
This trial tests a short, high-dose radiation treatment for early-stage prostate cancer. It uses MRI to guide the treatment precisely, which may reduce side effects and shorten treatment time.
This study tests a higher dose of radiation for prostate cancer using an MRI-guided machine (MR-Linac). It aims to see if a more targeted dose can be safely given to the tumor while protecting healthy tissue.
This trial tests whether a single, image-guided radiation treatment can treat intermediate-risk prostate cancer while better protecting the urethra (the urine tube). It may help patients get effective cancer control with potentially fewer urinary side effects, depending on the results.
Hear when a new Prostate cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.